In vitro and in vivo pharmacokinetic characterizations of AMG 900, an orally bioavailable small molecule inhibitor of aurora kinases

Liyue HuangPharmacokinetics and Drug Metabolism, Amgen Inc., Cambridge, MA, USA

Xuhai BePharmacokinetics and Drug Metabolism, Amgen Inc., Cambridge, MA, USA

Loren BerryPharmacokinetics and Drug Metabolism, Amgen Inc., Cambridge, MA, USA

Earl MoorePharmacokinetics and Drug Metabolism, Amgen Inc., Cambridge, MA, USA

Brett JanoskyPharmacokinetics and Drug Metabolism, Amgen Inc., Cambridge, MA, USA

Mary WellsPharmacokinetics and Drug Metabolism, Amgen Inc., Cambridge, MA, USA

Wei-Jian PanPharmacokinetics and Drug Metabolism, Amgen Inc., Cambridge, MA, USA

Zhiyang ZhaoPharmacokinetics and Drug Metabolism, Amgen Inc., Cambridge, MA, USA

Min-Hwa Jasmine LinPharmacokinetics and Drug Metabolism, Amgen Inc., Cambridge, MA, USACorrespondence[email protected]

Your download is now in progress and you may close this window